MARKET

BBI

BBI

Brickell Biotech Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3300
+0.1219
+58.58%
After Hours: 0.3281 -0.0019 -0.58% 19:59 01/18 EST
OPEN
0.2799
PREV CLOSE
0.2081
HIGH
0.3960
LOW
0.2600
VOLUME
230.23M
TURNOVER
--
52 WEEK HIGH
1.700
52 WEEK LOW
0.2031
MARKET CAP
37.97M
P/E (TTM)
-0.4294
1D
5D
1M
3M
1Y
5Y
DWAC, BTCS and BTCM among mid-day movers
Gainers: Brickell Biotech (NASDAQ:BBI) +69%. Mainz (NASDAQ:MYNZ) +34%. NeuroMetrix (NASDAQ:NURO) +33%. Activision Blizzard (NASDAQ:ATVI) +25%. Vinco Ventures (NASDAQ:BBIG) +21%. DatChat (NASDAQ:DATS) +19%. InnSuites Hospitality Trust (NYSE:IHT) +18%. Digit...
Seekingalpha · 7h ago
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
Upgrades
Benzinga · 10h ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Benzinga · 11h ago
BRIEF-Brickell Says Nasdaq Granted Additional 180 Days To Regain Compliance With Requirement
reuters.com · 12/14/2021 22:21
Brickell Biotech Q3 EPS $(0.16) Down From $(0.15) YoY, Sales $132.00K Miss $150.00K Estimate
Brickell Biotech (NASDAQ:BBI) reported quarterly losses of $(0.16) per share. This is a 6.67 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of
Benzinga · 11/09/2021 22:27
Brickell Biotech EPS misses by $0.03, misses on revenue
Brickell Biotech (NASDAQ:BBI): Q3 GAAP EPS of -$0.16 misses by $0.03. Revenue of $0.13M (-7.1% Y/Y) misses by $0.02M. Press Release
Seekingalpha · 11/09/2021 21:10
Brickell Biotech's Return On Capital Employed Insights
Benzinga Pro data, Brickell Biotech (NASDAQ:BBI) reported Q2 sales of $151.00 thousand. Earnings fell to a loss of $11.58 million, resulting in a 28.62% decrease from last quarter.
Benzinga · 11/09/2021 16:21
-- Earnings Flash (BBI) BRICKELL BIOTECH Reports Q3 Revenue $0.1M, vs. Street Est of $0.15M
MT Newswires · 11/09/2021 16:20
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BBI. Analyze the recent business situations of Brickell Biotech Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

50.00%Strong Buy
50.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average BBI stock price target is 5.00 with a high estimate of 6.00 and a low estimate of 4.000.
High6.00
Average5.00
Low4.000
Current 0.3300
EPS
Actual
Estimate
-0.13-0.10-0.06-0.03
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 51
Institutional Holdings: 8.23M
% Owned: 7.15%
Shares Outstanding: 115.05M
TypeInstitutionsShares
Increased
11
498.93K
New
3
267.69K
Decreased
6
555.78K
Sold Out
6
59.59K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-4.73%
Pharmaceuticals & Medical Research
-1.37%
Key Executives
Chairman/Co-Founder/Director
Reginald Hardy
Chief Executive Officer/Director
Robert Brown
Co-Founder/Chief Operating Officer/Secretary
Andrew Sklawer
Chief Financial Officer
Albert Marchio
Chief Accounting Officer/Controller
Jose Breton
Chief Compliance Officer/General Counsel/Secretary
David McAvoy
Other
Deepak Chadha
Independent Director
Gary Lyons
Independent Director
Vijay Samant
Independent Director
Dennison Veru
No Data
About BBI
Brickell Biotech, Inc. is a clinical-stage pharmaceutical company. The Company focuses on the development of therapeutics for the treatment of skin diseases. The Company's Phase III clinical-stage investigational product candidate, sofpironium bromide, is a chemical entity that belongs to a class of medications called anticholinergics is for the treatment of primary axillary (underarm) hyperhidrosis. The Company is also conducting early research programs targeting various skin diseases.

Webull offers kinds of Brickell Biotech Inc stock information, including NASDAQ:BBI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BBI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BBI stock methods without spending real money on the virtual paper trading platform.